RecruitingNCT06852469
Lorazepam and medication response in veterans with PTSD
About this title
Read the official source — NCT06852469Medication studyAges 18–65United States
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- San DiegoSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 1, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 150
- Sponsor
- VA Office of Research and Development
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06852469
- Official title
Show the full official title
Individualized Computational Assessment of the Effects of GABA Receptor Modulation in Posttraumatic Stress Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
San Diego
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is VA Office of Research and Development, a government agency.
Does this study involve medication?
Yes. The study involves medication, including Lorazepam 1 mg tablet and Placebo tablet.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
